CompaniesAgensys

Agensys

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (10)
View all

Total Trials

10

As Lead Sponsor

2

As Collaborator

8

Total Enrollment

394

By Phase

PHASE2: 2PHASE1: 8

By Status

COMPLETED: 8TERMINATED: 2
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Today
NCT00519233
NCT00902291
NCT01166490
NCT01114230
NCT01409135
NCT01672775
NCT01608711
Hover over trial bars to see details

Recent Trials

NCT01608711Lead Sponsor
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
PHASE2Completed
2 participants
Started: Aug 7, 2012 · Completed: Nov 16, 2015
NCT01672775Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology
PHASE1Completed
34 participants
Started: Jul 18, 2012 · Completed: Feb 21, 2017
NCT01409135Collaborator
A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4
PHASE1Completed
34 participants
Started: Jul 11, 2011 · Completed: Apr 27, 2015
NCT01114230Collaborator
A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer
PHASE1Completed
26 participants
Started: Aug 31, 2010 · Completed: Nov 30, 2012
NCT01166490Collaborator
A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
PHASE1Completed
51 participants
Started: Jul 31, 2010 · Completed: Jul 31, 2013
View all 10 trials →
Related Companies
Astellas Pharma
acquired